Abstract

Objective:The brain relies on the glymphatic system to clear metabolic wastes and maintain brain homeostasis to fulfill its functions better. Yet, the complexity of the glymphatic flow and clearance and its changes in HIV infection and its role in neurocognitive dysfunction remain poorly understood. This study aims to explore the impact of HIV and combination antiretroviral therapy (cART) on the glymphatic system and establish a potential biomarker of HIV-associated neurocognitive disorders (HAND).MethodsHere, we examined the glymphatic profiles of middle-aged virosuppressed patients with HIV (n = 27) receiving cART over 1–6 years and healthy controls (n = 28) along the perivascular space (PVS) using diffusion tensor image analysis along the perivascular space (ALPS) with guided and unguided approaches. We later combined data from these analyses to investigate MRI glymphatic correlates of cognitive impairment and other clinical tests of HIV (CD4+ T-cell counts and CD4+/CD8+ ratio).ResultsWe found that glymphatic function as measured by the ALPS index increased significantly in the right and left PVSs of patients with HIV having cART. On antiretroviral therapy, a changing pattern in glymphatic clearance function in patients with HIV having cART correlated with attention and working memory. Duration on cART was also associated with cognitive performances of abstract and executive function and learning and memory.ConclusionThese findings provide MRI evidence of the presence of HIV-induced changes in the glymphatic flow and clearance, which might underlie cognitive impairment among patients with HIV having cART. An increase in the glymphatic activity might reflect a compensatory mechanism to regulate microenvironment homeostasis compromised by HIV. This compensation might be necessary to maintain the proper functioning of the brain while coping with HIV pathology. These findings also shed light on the clinical importance of evaluating glymphatic function based on the ALPS index and suggest that improving the glymphatic system may serve as an alternative therapeutic strategy for HAND.

Highlights

  • Human immunodeficiency virus neuroinflammation has been associated with the pathogenesis of HIV-associated neurocognitive disorders (HAND) [1]

  • We evaluated the glymphatic system in cARTtreated patients with HIV using the diffusion tensor imaging (DTI)-ALPS index, which is the ratio of diffusivity toward the PVS

  • We found that the DTI-ALPS index in patients with HIV having combination antiretroviral therapy (cART) was high

Read more

Summary

Introduction

Human immunodeficiency virus neuroinflammation has been associated with the pathogenesis of HIV-associated neurocognitive disorders (HAND) [1]. Despite antiretroviral therapy, several studies have reported persisting cognitive dysfunction in patients with HIV having cART, especially in attention and working memory, executive function, motor control, and visual processing speed [6–8]. The glymphatic system refers to the drainage pathways through which metabolic waste products and other undesirable components get flushed out of the brain, thereby stabilizing microenvironmental homeostasis and providing suitable working conditions for the brain parenchymal cells [9, 10]. CSF-ISF exchange is enabled by the polarization processes of aquaporin-4 (AQP4) water channels at the end-feet of astrocytes. This exchange facilitates the drainage of metabolic wastes and other soluble particles such as glucose, lipids, signaling molecules, and apolipoprotein E (apoE) via paravenous channels [11, 12]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call